Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients

Recruiting

A Pilot Randomized Controlled Trial of the Use of a Website About Radioactive Iodine Symptom Management in Patients With Thyroid Cancer

Who can join

Ages 18 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

* Age 18 or older (papillary or follicular carcinoma)
* Diagnosed with differentiated thyroid cancer
* Received radioactive iodine (RAI) treatment less than or equal to three years ago.
* Mild to moderate symptoms of RAI
* Able to provide informed consent in English
* Access to a computer, tablet, or smartphone with internet connectivity

Exclusion Criteria:

* A condition that precludes providing informed consent or completing study procedures (cognitive or psychiatric condition, hearing problems) as identified by the patient's physician or as assessed by a trained study team member.

About the study

The goal of this clinical trial is to learn if adult patients diagnosed with differentiated thyroid cancer can easily use and benefit from an online tool aimed to provide patients with educational resources and symptom management strategies to improve their quality of life after radioactive iodine (RAI) treatment. The main questions it aims to answer are:

1. Can patients easily use and benefit from the RAI Support intervention? 2. Does RAI Support improve health-related quality of life (overall well-being) compared to usual care?

This research will help test better digital tools to support thyroid cancer survivors in managing their health after RAI treatment.

Researchers will compare RAI Support to treatment as usual (a publicly available informational website about thyroid cancer) to see if RAI Support works to improve patients' overall well-being.

Participants will:

1. Receive access to RAI Support or an informational website (treatment as usual) for four weeks. 2. Use the assigned website once a week for up to four weeks. 3. Complete two online questionnaires (an initial questionnaire and a final questionnaire after four weeks of using the assigned website) about symptoms related to RAI treatment, mood, and confidence in managing symptoms. 4. Complete an optional 60 minute virtual interview about your experiencing using the assigned website.

What is being tested

Radioactive Iodine Support (RAI Support) (behavioral)
Treatment as Usual (TAU) (other)

Sponsor: Georgetown University · Participants: 88 · Started: Oct 2, 2025

Contact the study team

Alaina L Carr, PhD · Phone: 202-687-0958

Official record on ClinicalTrials.gov — NCT06853925

Locations in the U.S.

District of Columbia

Georgetown University, Washington D.C.

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.